Cargando…

Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain Changes

BACKGROUND: Cognitive behavioral therapy (CBT) reduces anxiety symptoms in patients with Parkinson’s disease (PD). OBJECTIVE: The objective of this study was to identify changes in functional connectivity in the brain after CBT for anxiety in patients with PD. METHODS: Thirty-five patients with PD a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carey, Guillaume, Lopes, Renaud, Moonen, Anja J.H., Mulders, Anne E.P., de Jong, Joost J.A., Kuchcinski, Gregory, Defebvre, Luc, Kuijf, Mark L., Dujardin, Kathy, Leentjens, Albert F.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912714/ https://www.ncbi.nlm.nih.gov/pubmed/36591659 http://dx.doi.org/10.3233/JPD-223527

Ejemplares similares

Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity
por: Carey, Guillaume, et al.
Publicado: (2023)

Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
por: Moonen, Anja J.H., et al.
Publicado: (2021)

Posterior Cortical Cognitive Deficits Are Associated With Structural Brain Alterations in Mild Cognitive Impairment in Parkinson’s Disease
por: Devignes, Quentin, et al.
Publicado: (2021)

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review
por: Carey, Guillaume, et al.
Publicado: (2020)

Usability of the Experience Sampling Method in Parkinson's Disease on a Group and Individual Level
por: Mulders, Anne E.P., et al.
Publicado: (2020)

Clinical Markers of Anxiety Subtypes in Parkinson Disease
por: Broen, Martinus P. G., et al.
Publicado: (2018)

Hallucinations and conscious access to visual inputs in Parkinson’s disease
por: Lefebvre, Stéphanie, et al.
Publicado: (2016)

Texture-based markers from structural imaging correlate with motor handicap in Parkinson’s disease
por: Betrouni, Nacim, et al.
Publicado: (2021)

Ventilatory Dysfunction in Parkinson’s Disease
por: Baille, Guillaume, et al.
Publicado: (2016)

Mobile Health Daily Life Monitoring for Parkinson Disease: Development and Validation of Ecological Momentary Assessments
por: Habets, Jeroen, et al.
Publicado: (2020)

Covid Proof Self‐Management Training for Caregivers of Patients with Parkinson's Disease
por: Duits, Annelien A., et al.
Publicado: (2020)

Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease
por: Hassan, M., et al.
Publicado: (2017)

Impaired Early Attentional Processes in Parkinson’s Disease: A High-Resolution Event-Related Potentials Study
por: Bocquillon, Perrine, et al.
Publicado: (2015)

Relationship Dynamics of Couples Facing Advanced-Stage Parkinson’s Disease: A Dyadic Interpretative Phenomenological Analysis
por: Constant, Emilie, et al.
Publicado: (2022)

Cortical Oscillations during Gait: Wouldn’t Walking Be So Automatic?
por: Delval, Arnaud, et al.
Publicado: (2020)

Deep Brain Stimulation for Treatment-Resistant Depression: Towards a More Personalized Treatment Approach
por: Roet, Milaine, et al.
Publicado: (2020)

Are Upper-Body Axial Symptoms a Feature of Early Parkinson’s Disease?
por: Moreau, Caroline, et al.
Publicado: (2016)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease
por: Erga, Aleksander H., et al.
Publicado: (2023)

Transcranial sonography findings related to depression in parkinsonian disorders: cross-sectional study in 126 patients
por: Bouwmans, Angela E.P., et al.
Publicado: (2016)

Corrigendum to “The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease” [Contemp. Clinic. Trials Commun. 32 (2023) 101080]
por: Erga, Aleksander H., et al.
Publicado: (2023)

Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
por: Pontone, Gregory M., et al.
Publicado: (2019)

Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
por: Pontone, Gregory M., et al.
Publicado: (2020)

Early occurrence of inspiratory muscle weakness in Parkinson’s disease
por: Baille, Guillaume, et al.
Publicado: (2018)

An fMRI study into emotional processing in Parkinson’s disease: Does increased medial prefrontal activation compensate for striatal dysfunction?
por: Moonen, Anja J. H., et al.
Publicado: (2017)

Unraveling the Relationship between Motor Symptoms, Affective States and Contextual Factors in Parkinson’s Disease: A Feasibility Study of the Experience Sampling Method
por: Broen, Martijn P. G., et al.
Publicado: (2016)

Role of Basal Ganglia Circuits in Resisting Interference by Distracters: A swLORETA Study
por: Bocquillon, Perrine, et al.
Publicado: (2012)

Ventral Capsule/Ventral Striatum Stimulation in Obsessive‐Compulsive Disorder: Toward a Unified Connectomic Target for Deep Brain Stimulation?
por: van der Vlis, Tim A.M. Bouwens, et al.
Publicado: (2020)

Freezing during tapping tasks in patients with advanced Parkinson’s disease and freezing of gait
por: Delval, Arnaud, et al.
Publicado: (2017)

Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkers
por: Taymans, Jean-Marc, et al.
Publicado: (2023)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
por: Hopes, Lucie, et al.
Publicado: (2016)

Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations
por: Mestre, Tiago A., et al.
Publicado: (2021)

The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s disease
por: Wolters, A. F., et al.
Publicado: (2020)

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
por: Grolez, Guillaume, et al.
Publicado: (2015)

Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
por: Dujardin, Kathy, et al.
Publicado: (2020)

Machine learning prediction of motor response after deep brain stimulation in Parkinson’s disease—proof of principle in a retrospective cohort
por: Habets, Jeroen G.V., et al.
Publicado: (2020)

Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy
por: Tard, Céline, et al.
Publicado: (2020)

Effectiveness, Timing and Procedural Aspects of Cognitive Behavioral Therapy after Deep Brain Stimulation for Therapy-Resistant Obsessive Compulsive Disorder: A Systematic Review
por: Görmezoğlu, Meltem, et al.
Publicado: (2020)

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_75ill38v7v70v39gdm0ag6o3am